Trader’s Buzz: IsoRay (ISR), Copa Holdings (CPA), Synaptics (SYNA), Jarden (JAH), Ariad (ARIA), Intel (INTC)

IsoRay, Inc. (ISR) shares are currently printing a 6% uptick from the previous close. The company today announced that the University of Pittsburgh School of Medicine reports that IsoRay’s Cesium-131 Prostate Treatment provided strong cancer control, lower side effects, providing men improved quality of life. ISR recently traded at $1.40. The name, currently valued at […] View the full post at: Trader’s Buzz: IsoRay (ISR), Copa Holdings (CPA), Synaptics (SYNA), Jarden (JAH), Ariad (ARIA), Intel (INTC) Related posts: Apple to Use AMD Chips? Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock